Patron: Deutsche Gesellschaft für Kardiologie-, Herz- und Kreislaufforschung e.V.
Congress for Interventional Heart Medicine, Munich
Review: heartlive 2025
Outlook 2026: Highlights in Interventional Heart Medicine
In early December 2025, heartlive once again took place in Munich. Prof. Dr. Daniel Steven, Cologne, served as Congress President. All participants were delighted with the exceptionally positive feedback!
We are pleased to welcome you back to Munich on December 3–4, 2026. The congress presidency will then be assumed by Prof. Dr. Norbert Frey from Heidelberg. heartlive 2026 will once again present the most important developments in interventional heart medicine. Technical and procedural innovations — particularly for older and multimorbid patients — will be highlighted alongside their scientific context. More than 20 live cases from leading centers will be complemented by state‑of‑the‑art lectures on current therapeutic challenges.
The accompanying workshop program “heartdays” will offer practical insights into numerous subfields of interventional heart medicine and foster personal exchange of experience.
We warmly welcome you and wish you an inspiring and collegial meeting!
We look forward to welcoming you to Munich!
Electrophysiology
Chairpersons Prof. Steven (Cologne) and Prof. Tilz (Lübeck) focus on ablation strategies and exciting fields like cardiac pacing, electrophysiology and other cardiac rhythm disorders.
Heart valve therapies
Focus of valvelive are TAVR innovations, as well as options for mitral- and tricuspid valve therapy, including procedural and post procedural aspects like optimal access ways or correct follow-up care.
Complex coronary interventions
pci live: focus on the handling of risk patients with regard to coronary heart disease and heart failure. Complex coronary interventions (CTOs, bifurcations, left main ... ) are demonstrated live from several centres.